COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific Brief
World Health Organisation
Topics & Concepts
MedicineAngiotensin Receptor BlockersCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPharmacologyReceptorAngiotensin-converting enzymeVirologyInternal medicineInfectious disease (medical specialty)DiseaseBlood pressureOutbreakCOVID-19 Clinical Research Studies